News

Overall survival after HCT for high-risk features in patients with SDS was superior to OS for HCT for MDS/AML, particularly ...
Results of a randomized, placebo-controlled study demonstrated avatrombopag achieved the primary endpoint of platelet response in heavily pretreated pediatric patients with persistent or chronic ITP.
Relative survival increased from 64% to 66%, overall survival from 54% to 55%, and lymphoma-specific survival from 64% to 66%.
Researchers examined patient-reported outcomes for quality of life following Mohs micrographic surgery for facial skin cancer.
Using data from the Global Burden of Disease 2021 database, researchers identified specific etiologies and other factors contributing to the burden of primary liver cancer in patients across the ...
Researchers found a significant tradeoff between harms and benefits for patients who received an ICI plus chemotherapy in the first-line setting.
A literature review explored the omics-based approach to symptom biomarker identification to determine how these biomarkers affect symptom management strategies.
HealthDay News — Different measurement tools and diagnostic criteria show low-to-moderate agreement for diagnosing breast cancer-related lymphedema (BCRL), according to a study published in the April ...
Combination treatment with a PARP inhibitor and an anti-angiogenic agent did not improve PFS when compared to chemotherapy or ...
Researchers found that C-reactive protein is a biomarker for psychological stress in caregivers of patients with primary malignant brain tumor.
Five-year data from the KEYNOTE-048 trial support the use of pembrolizumab and pembrolizumab-chemotherapy as standards of care, researchers wrote.
Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.